We next tested the effect of pharmacological mTOR inhibition on the accumulation of toxic α-synuclein, which is closely linked to PD pathology and known to promote ER stress (Wang et al., 2012; Kawahata et al., 2022). The gene discussed is MTOR; the disease is Parkinson disease.